Polymorphisms in the Nrf2 promoter region have been linked to higher CRC risk, while high nuclear expression of Nrf2 correlates with increased antioxidant enzyme levels and lower inflammatory markers in colonic mucosa [206,207]. The gene discussed is NFE2L2; the disease is colorectal carcinoma.